Source: Annual Congress 2001 - Asthma monitoring and therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. F. Kalyoncu, G. Karakaya, E. Yilmaz, B. Balci, A. Karaduman, U. Yasavul (Ankara, Turkey). Analgesic intolerance with or without bronchial asthma: is there a marker?. Eur Respir J 2001; 16: Suppl. 31, 1802

Member's Comments

No comment yet.

Related content which might interest you: Bronchial asthma: what is different in patients with and without chronic cough? Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Treatment of bronchial asthma and wheezing disorders: chronic Source: ERS Skills Course 2016 Year: 2016 Treatment of bronchial asthma and wheezing disorders: acute Source: ERS Skills Course 2016 Year: 2016 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Bronchial hyperreactivity in asthma: relationship with clinical severity and therapy Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005 Decametoxine influence on bronchial hyperreactivity in patients with bronchial asthma Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Bronchial thermoplasty: an option for treating asthma? Source: Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases Year: 2012 Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Inhaled corticosteroids in treatment of patients with intermittent bronchial asthma: yes or no? Source: Eur Respir J 2005; 26: Suppl. 49, 503s Year: 2005 Does a correlation exist between bronchial hyperresponsiveness and therapy in asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Corticosteroid-dependent bronchial asthma: lack of a control of disease Source: Eur Respir J 2002; 20: Suppl. 38, 110s Year: 2002 Role of of symbicort in treatment of bronchial asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 A new asthma severity index: a predictor of near-fatal asthma? Source: Eur Respir J 2001; 18: 272-278 Year: 2001 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 Nebulized therapy in bronchial asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Is bronchial hyperresponsiveness(BHR) a diagnostic feature of asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 454s Year: 2001